Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Lallemant

Showing results (21-30 of 97) with videos related to

Pageof 10
Sort By:
BMC Public Health|September 25, 2020
Risky injection practices and HCV awareness in Chiang Mai Province, Thailand: a respondent-driven sampling study of people who inject drugsMyrtille Prouté, Sophie Le Coeur, Métrey H Tiv, et al.
AIDS Patient Care and Stds|October 9, 2007
Maternal HIV-1 DNA load and mother-to-child transmissionNils D Arvold, Nicole Ngo-Giang-Huong, Kenneth McIntosh, et al.
AIDS Research and Human Retroviruses|September 22, 2010
Hematological safety of perinatal exposure to zidovudine in uninfected infants born to HIV type 1-infected women in ThailandNelly Briand, Sophie Le Coeur, Gonzague Jourdain, et al.
Expert Opinion on Pharmacotherapy|March 28, 2017
Antiretroviral treatment in HIV-infected children who require a rifamycin-containing regimen for tuberculosisHelena Rabie, Eric H Decloedt, Anthony J Garcia-Prats, et al.
The Journal of Antimicrobial Chemotherapy|October 9, 2009
Influence of CYP2B6 polymorphisms on the persistence of plasma nevirapine concentrations following a single intra-partum dose for the prevention of mother to child transmission in HIV-infected Thai womenSoranun Chantarangsu, Tim R Cressey, Surakameth Mahasirimongkol, et al.
Antiviral Therapy|October 4, 2014
Lopinavir/ritonavir plus lamivudine and abacavir or zidovudine dose ratios for paediatric fixed-dose combinationsNaïm Bouazza, Frantz Foissac, Floris Fauchet, et al.
Plos Clinical Trials|May 4, 2007
Haematological safety of perinatal zidovudine in pregnant HIV-1-infected women in Thailand: secondary analysis of a randomized trialNelly Briand, Marc Lallemant, Gonzague Jourdain, et al.
The Journal of Obstetrics and Gynaecology Research|August 27, 2009
Risk factors of preterm delivery in HIV-infected pregnant women receiving zidovudine for the prevention of perinatal HIVPatrinee Traisathit, Jean Yves Mary, Sophie Le Coeur, et al.
The Pediatric Infectious Disease Journal|July 29, 2021
Effective and Safe Daclatasvir Drug Exposures Predicted in Children Using Adult FormulationsTim R Cressey, Maggie Abbassi, Marc Lallemant, et al.
The Journal of Infectious Diseases|November 17, 2007
Risk factors for in utero or intrapartum mother-to-child transmission of human immunodeficiency virus type 1 in ThailandGonzague Jourdain, Jean-Yves Mary, Sophie Le Coeur, et al.
Pageof 10

Showing results (21-30 of 97) with videos related to

Sort By:
Pageof 10
BMC Public Health|September 25, 2020
Risky injection practices and HCV awareness in Chiang Mai Province, Thailand: a respondent-driven sampling study of people who inject drugsMyrtille Prouté, Sophie Le Coeur, Métrey H Tiv, et al.
AIDS Patient Care and Stds|October 9, 2007
Maternal HIV-1 DNA load and mother-to-child transmissionNils D Arvold, Nicole Ngo-Giang-Huong, Kenneth McIntosh, et al.
AIDS Research and Human Retroviruses|September 22, 2010
Hematological safety of perinatal exposure to zidovudine in uninfected infants born to HIV type 1-infected women in ThailandNelly Briand, Sophie Le Coeur, Gonzague Jourdain, et al.
Expert Opinion on Pharmacotherapy|March 28, 2017
Antiretroviral treatment in HIV-infected children who require a rifamycin-containing regimen for tuberculosisHelena Rabie, Eric H Decloedt, Anthony J Garcia-Prats, et al.
The Journal of Antimicrobial Chemotherapy|October 9, 2009
Influence of CYP2B6 polymorphisms on the persistence of plasma nevirapine concentrations following a single intra-partum dose for the prevention of mother to child transmission in HIV-infected Thai womenSoranun Chantarangsu, Tim R Cressey, Surakameth Mahasirimongkol, et al.
Antiviral Therapy|October 4, 2014
Lopinavir/ritonavir plus lamivudine and abacavir or zidovudine dose ratios for paediatric fixed-dose combinationsNaïm Bouazza, Frantz Foissac, Floris Fauchet, et al.
Plos Clinical Trials|May 4, 2007
Haematological safety of perinatal zidovudine in pregnant HIV-1-infected women in Thailand: secondary analysis of a randomized trialNelly Briand, Marc Lallemant, Gonzague Jourdain, et al.
The Journal of Obstetrics and Gynaecology Research|August 27, 2009
Risk factors of preterm delivery in HIV-infected pregnant women receiving zidovudine for the prevention of perinatal HIVPatrinee Traisathit, Jean Yves Mary, Sophie Le Coeur, et al.
The Pediatric Infectious Disease Journal|July 29, 2021
Effective and Safe Daclatasvir Drug Exposures Predicted in Children Using Adult FormulationsTim R Cressey, Maggie Abbassi, Marc Lallemant, et al.
The Journal of Infectious Diseases|November 17, 2007
Risk factors for in utero or intrapartum mother-to-child transmission of human immunodeficiency virus type 1 in ThailandGonzague Jourdain, Jean-Yves Mary, Sophie Le Coeur, et al.
Pageof 10